Surface Oncology Inc

NASDAQ:SURF   3:59:54 PM EDT
7.73
-0.04 (-0.52%)
Products

Surface Oncology’s SRF617 Receives Orphan Drug Designation From FDA For Treatment Of Pancreatic Cancer

Published: 03/30/2021 20:47 GMT
Surface Oncology Inc (SURF) - Surface Oncology’s Srf617 Receives Orphan Drug Designation From FDA for Treatment of Pancreatic Cancer.